A new scientific study identified taurine, a key ingredient in some energy drinks and protein powders, as a key regulator of myeloid cancers such as leukaemia. As leukaemia cells drink up taurine, it promotes glycolysis (a breakdown of glucose to produce energy) to feed cancer growth, researchers said. Previously, taurine has been proven useful as a supplement in chemotherapy.